IFCC-EFLM
EuroMedLab 2025
Pioneering breakthroughs in healthcare. For everyone. Everywhere.
Every blood test tells someone’s story.
And just as that blood is unique, so is your network, your lab, your processes, and your staff.
Setting a new bar in performance, we are delivering bespoke solutions that go beyond standardization to deliver efficiency and intelligence across your network. Our next level of system innovation is thoughtfully engineered to better suit your distinct needs, while caring for the morale and safety of your team and our planet.
Our expert team walks beside you: our engineers, scientists, physicians, workflow specialists and service personnel are all working day after day to bring you the tailored solutions that make it easier for your staff, your lab, and your institution – because we understand the vital role you play in patients’ lives with every test.
Thank you for joining us at WORLDLAB - EUROMEDLAB ROMA 2023 to meet our team of experts and learn about innovations and trends in clinical diagnostics and point-of-care testing. We look forward to seeing you at EUROMEDLAB BRUSSELS 2025.
Don't miss the latest! Register for exclusive access to expert videos and insights and get personalized recommendations.
We ❤ the lab: Care for the care team
Labs play a critical role in healthcare delivery.
But it’s a tough place to work right now. It’s difficult to attract and retain a skilled workforce, and current staff are experiencing high levels of burnout. Just simplifying operations won’t solve these issues. Care team well-being includes a safe, predictable workplace. One with a reduced burden of stringent regulatory requirements and full of development opportunities. Visit us and learn how to improve the morale and safety of your team – and care for our planet – all while making the lab the hero of the health system.
4 ways to care for healthcare professionals who care for patients
Workforce shortage is one of the biggest challenges for healthcare systems around the globe. Watch for four ways to improve and address the issue from a thought leader in healthcare.
Helping you meet environmental, health, and safety sustainability goals
Did you know our sustainability initiatives span the globe? Discover how green initiatives help improve your lab’s environmental footprint without compromising workflow, quality, or safety.
How can you make hematology testing a more seamless operation?
Start by eliminating daily maintenance and reducing the amount of valuable technician time that gets spent at the analyzer with automation.1 Then, use intelligence to empower staff of all skill levels to rapidly act on results.
Strategies for going beyond standardization
The definition of standardization across a health network
is shared reagents, common user interfaces, and reduced training needs. With continued consolidation of healthcare organizations and the ever-changing dynamics of the clinical diagnostics market, today’s laboratories must be agile–going beyond just standardization.
Integrated Automation in 6m2
Powered for workflow and workforce efficiency, the Atellica® Solution delivers control and simplicity so you can drive better outcomes. Join our expert for a high-level overview of Atellica Integrated Automation.
How does the IMMULITE® 2000 XPi address common challenges faced by specialty laboratories?
Leverage the power of open connectivity with POC Informatics
Save time and money by consolidating middleware with a truly open solution. Enhanced data analytics ensure quality control and integrated e-learning streamlines staff training. This centralized approach to data, device, and staff management enables efficient workflows and informed decisions, faster.
Acute care through the lens of critical assays
Only 1 in 10 emergency department patients
with chest pain are experiencing an AMI.2 The other nine are taking up an ED bed waiting to be discharged. Clinicians are waiting on actionable test results to effectively treat patients – in the surgical suite, wards, or the ED. Meeting guidelines and TAT goals with confidence can be one of the lab’s greatest challenges.
Driving cardiac testing forward ─ everywhere
Whether it's a full cardiac menu with results in minutes in the lab, or an 8-minute venous or fingerstick high-sensitivity troponin I at the point of care, Siemens Healthineers offers access to manage cardiac patients with increased speed, insight and confidence–no matter where you are.
To meet the age-old problem of increasing test volumes, Dr. Lal Pathlabs typically added instruments. Today this high-volume reference network in India has a modern solution.
Deliver patient-side critical care testing in less than 1 minute
Patient-side testing is about more than a location. It’s staying focused on the patient. The epoc® Blood Analysis System connects the entire team, so it doesn’t matter if the laboratory staff and caregivers work in different parts of the hospital. With the epoc System, they stand together to advance care delivery.
Meeting the rising tide of chronic diseases
Responsible for 63% of all deaths,
non-communicable diseases will cost the world $30 trillion by 2030.3 Not only did the pandemic delay care for chronic disease patients, but it brought about further democratization of testing. Patients with liver disease, kidney disease, diabetes, and allergies are taking command of their health. Clinicians are looking for tools for risk assessment.
Liver Disease: A Silent Killer
Utility of noninvasive tests such as the ELF Test in the NALFD/NASH patient referral pathway.
Urine: A Liquid Lens Into Your Health
In this 5-part YouTube series, learn about the earliest urine tests to the invention of modern urinalysis in the 1950s, all the way to the future of urinalysis. Along the way, you'll learn about the importance of urine testing: a true liquid lens into our health.
Improve management of bleeding patients
While the majority of von Willebrand disease (VWD) patients suffer from a congenital, lifelong bleeding disorder, certain chronic diseases and therapies can lead to acquired VWD. Check out our resources for recent testing guidelines and advancements in VWD diagnostics.
Thank you for joining us in Rome in 2023.
We look forward to seeing you in Brussels in 2025
Join us at EuroMedLab Brussels 2025, where we will share our newest innovations to help you deliver high value care, and confidently provide the answers your clinicians and patients expect.
Congress Overview
EUROMEDLAB Brussels 2025
Congress Dates: 18-22 May 2025
Exhibition Dates: 19-22 May 2025
Venue: Brussels Expo Map:
Hosted by
Availability of products mentioned herein may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.
Atellica, epoc, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.
Atellica Hematology Analyzers not available for sale in the U.S. The products/features mentioned here are not commercially available in all countries. Their future availability cannot be guaranteed. Track-based automation connectivity for the Atellica HEMA Analyzers is under development. Not available for sale. Future availability cannot be guaranteed.
https://www.acep.org/imports/clinical-and-practice-management/resources/administration/observation-svcs/chest-pain-units-in-emergency-departments/
https://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf
In the U.S., the ELF Test is not for use in the diagnosis of NASH or for the staging of fibrosis. The ELF Test is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events.
Sources for 3D VWF visual:
PDB: 1SQ0
Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS, Mosyak L. Crystal structure of the complex of the wild-type von Willebrand factor A1 domain and glycoprotein Ib alpha at 2.6 angstrom resolution. 2004. doi: 10.2210/pdb1SQ0/pdb
Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS, Mosyak L. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem. 2004;279:23327-34. doi: 10.1074/jbc.M401659200